
|Articles|October 1, 2019
- Pharmaceutical Executive-10-01-2019
- Volume 39
- Issue 10
Pharmaceutical Executive, October 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Tech Tour for the C-Suite: Pharma’s Digital Futureover 6 years ago
It Starts with a Scribbleover 6 years ago
Olivier Laureau, Servier: Free to Grow, Innovateover 6 years ago
Corey McCann: A PDT Pioneerover 6 years ago
Data Shape-Up: Striving to Standardizeover 6 years ago
Policy Sync-Up: The Drug Importation Conundrumover 6 years ago
Validating Value Data: AI and Outcomesover 6 years ago
Underlying Platform: Data Unleashedover 6 years ago
Surfing the Wave: The Patient-Data Puzzleover 6 years ago
Where Does Europe’s Drug Industry Go from Here?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5




